newsfilter
← Latest News
GlobeNewswire·

Codiak BioSciences to Present at the 4th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, Mass., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ:CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that Douglas E.